Aminoleban EN


Indications and Reactions:

Role Indications Reactions
Secondary
Carcinoma Hepatocellular 24.5%
Ascites 16.3%
Hepatic Cirrhosis 14.3%
Oedema 12.2%
Hepatic Encephalopathy 8.2%
Prophylaxis Against Gastrointestinal Ulcer 8.2%
Drug Use For Unknown Indication 4.1%
Hepatic Neoplasm Malignant 4.1%
Ulcer 4.1%
Cancer Pain 2.0%
Hepatitis 2.0%
Hepatic Encephalopathy 50.0%
Rash 33.3%
Stevens-johnson Syndrome 16.7%
Concomitant
Hepatic Neoplasm Malignant 19.9%
Hepatic Cirrhosis 13.6%
Prophylaxis 10.8%
Hypertension 7.1%
Insomnia 6.0%
Drug Use For Unknown Indication 4.9%
Product Used For Unknown Indication 4.6%
Chronic Hepatitis C 3.7%
Gastritis 3.5%
Hiv Infection 3.2%
Constipation 3.1%
Hepatocellular Carcinoma 2.9%
Nail Ridging 2.8%
Hepatic Failure 2.4%
Gastric Ulcer 2.2%
Hyperammonaemia 2.2%
Ascites 1.9%
Hepatitis C 1.9%
Cataract 1.6%
Hepatic Encephalopathy 1.6%
Hepatic Encephalopathy 12.8%
Pyrexia 10.4%
Pneumocystis Jiroveci Pneumonia 8.8%
Palmar-plantar Erythrodysaesthesia Syndrome 7.2%
Rash 5.6%
Hepatic Neoplasm Malignant 4.8%
Portal Vein Thrombosis 4.8%
Renal Impairment 4.8%
Ascites 4.0%
Hepatic Failure 4.0%
Hepatic Function Abnormal 4.0%
Hyperammonaemia 4.0%
Liver Carcinoma Ruptured 4.0%
Liver Disorder 4.0%
Malaise 3.2%
Platelet Count Decreased 3.2%
Subcutaneous Abscess 3.2%
Diarrhoea 2.4%
Hepatic Cirrhosis 2.4%
Oesophageal Varices Haemorrhage 2.4%

Drug Data